[go: up one dir, main page]

ITMI940506A0 - Derivati chinzolilamminici attivi come alfa-antagonisti - Google Patents

Derivati chinzolilamminici attivi come alfa-antagonisti

Info

Publication number
ITMI940506A0
ITMI940506A0 ITMI940506A ITMI940506A ITMI940506A0 IT MI940506 A0 ITMI940506 A0 IT MI940506A0 IT MI940506 A ITMI940506 A IT MI940506A IT MI940506 A ITMI940506 A IT MI940506A IT MI940506 A0 ITMI940506 A0 IT MI940506A0
Authority
IT
Italy
Prior art keywords
chinzolilaminic
antagonists
alpha
derivatives active
derivatives
Prior art date
Application number
ITMI940506A
Other languages
English (en)
Inventor
Amedeo Leonardi
Gianni Motta
Carlo Boi
Testa Rodolfo
Original Assignee
Recordati Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati Chem Pharm filed Critical Recordati Chem Pharm
Publication of ITMI940506A0 publication Critical patent/ITMI940506A0/it
Priority to ITMI940506A priority Critical patent/IT1270993B/it
Priority to SI9530495T priority patent/SI0750614T1/xx
Priority to ES95911342T priority patent/ES2158938T3/es
Priority to PT95911342T priority patent/PT750614E/pt
Priority to ZA952208A priority patent/ZA952208B/xx
Priority to EP95911342A priority patent/EP0750614B1/en
Priority to AU18948/95A priority patent/AU1894895A/en
Priority to PCT/EP1995/001001 priority patent/WO1995025726A1/en
Priority to DK95911342T priority patent/DK0750614T3/da
Priority to IL11302495A priority patent/IL113024A/xx
Priority to JP52437095A priority patent/JP3683911B2/ja
Priority to AT95911342T priority patent/ATE201400T1/de
Priority to US08/716,160 priority patent/US5798362A/en
Priority to DE69521037T priority patent/DE69521037T2/de
Priority to TW084105132A priority patent/TW416951B/zh
Publication of ITMI940506A1 publication Critical patent/ITMI940506A1/it
Application granted granted Critical
Publication of IT1270993B publication Critical patent/IT1270993B/it
Priority to GR20010401292T priority patent/GR3036443T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
ITMI940506A 1994-03-18 1994-03-18 Derivati chinzolilamminici attivi come alfa-antagonisti IT1270993B (it)

Priority Applications (16)

Application Number Priority Date Filing Date Title
ITMI940506A IT1270993B (it) 1994-03-18 1994-03-18 Derivati chinzolilamminici attivi come alfa-antagonisti
DK95911342T DK0750614T3 (da) 1994-03-18 1995-03-17 Quinazolinyl-aminoderivater med alfa-antagonist-aktivitet
JP52437095A JP3683911B2 (ja) 1994-03-18 1995-03-17 α−拮抗活性を有するキナゾリニル−アミノ誘導体
PT95911342T PT750614E (pt) 1994-03-18 1995-03-17 Derivados de amino-quinazolinilo que possuem actividade antagonista alfa
ZA952208A ZA952208B (en) 1994-03-18 1995-03-17 Quinazolinyl-amino derivatives having alpha-antagonist activity
EP95911342A EP0750614B1 (en) 1994-03-18 1995-03-17 Quinazolinyl-amino derivatives having alpha-antagonist activity
AU18948/95A AU1894895A (en) 1994-03-18 1995-03-17 Quinazolinyl-amino derivatives having alpha-antagonist activity
PCT/EP1995/001001 WO1995025726A1 (en) 1994-03-18 1995-03-17 QUINAZOLINYL-AMINO DERIVATIVES HAVING α-ANTAGONIST ACTIVITY
SI9530495T SI0750614T1 (en) 1994-03-18 1995-03-17 Quinazolinyl-amino derivatives having alpha-antagonist activity
IL11302495A IL113024A (en) 1994-03-18 1995-03-17 Quinazolinyl-amino derivatives having alpha-antagonist activity their preparation and pharmaceutical compositions comprising them
ES95911342T ES2158938T3 (es) 1994-03-18 1995-03-17 Derivados de aminoquinazolina que tienen actividad alfa-antagonistas.
AT95911342T ATE201400T1 (de) 1994-03-18 1995-03-17 Chinazolinylamino derivate mit alfa-antagonist wirkung
US08/716,160 US5798362A (en) 1994-03-18 1995-03-17 Quinazolinyl-amino derivatives having α-antagonist activity
DE69521037T DE69521037T2 (de) 1994-03-18 1995-03-17 Chinazolinylamino derivate mit alfa-antagonist wirkung
TW084105132A TW416951B (en) 1994-03-18 1995-05-23 Quinazolinyl-amino derivatives having <alpha>-antagonist activity
GR20010401292T GR3036443T3 (en) 1994-03-18 2001-08-23 Quinazolinyl-amino derivatives having alpha-antagonist activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI940506A IT1270993B (it) 1994-03-18 1994-03-18 Derivati chinzolilamminici attivi come alfa-antagonisti

Publications (3)

Publication Number Publication Date
ITMI940506A0 true ITMI940506A0 (it) 1994-03-18
ITMI940506A1 ITMI940506A1 (it) 1995-09-18
IT1270993B IT1270993B (it) 1997-05-26

Family

ID=11368249

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI940506A IT1270993B (it) 1994-03-18 1994-03-18 Derivati chinzolilamminici attivi come alfa-antagonisti

Country Status (15)

Country Link
US (1) US5798362A (it)
EP (1) EP0750614B1 (it)
JP (1) JP3683911B2 (it)
AT (1) ATE201400T1 (it)
AU (1) AU1894895A (it)
DE (1) DE69521037T2 (it)
DK (1) DK0750614T3 (it)
ES (1) ES2158938T3 (it)
GR (1) GR3036443T3 (it)
IL (1) IL113024A (it)
IT (1) IT1270993B (it)
PT (1) PT750614E (it)
TW (1) TW416951B (it)
WO (1) WO1995025726A1 (it)
ZA (1) ZA952208B (it)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747490A (en) * 1995-09-29 1998-05-05 Merck & Co., Inc. Alpha 1b adrenergic receptor antagonists
WO1997020822A1 (en) * 1995-12-01 1997-06-12 Novartis Ag Quinazolin-2,4-diazirines as npy receptor antagonist
IT1286302B1 (it) * 1996-04-10 1998-07-08 Rotta Research Lab Chinazoline-4-amino-2-(piperidino-1-il-4-sostituite) ad attivita' anti-ipertensiva, procedimento per la loro preparazione e loro uso
GB9700504D0 (en) 1997-01-11 1997-02-26 Pfizer Ltd Pharmaceutical compounds
GB9711650D0 (en) 1997-06-05 1997-07-30 Pfizer Ltd Compounds useful in therapy
US7186726B2 (en) * 1998-06-30 2007-03-06 Neuromed Pharmaceuticals Ltd. Preferentially substituted calcium channel blockers
US6355641B1 (en) 1999-03-17 2002-03-12 Syntex (U.S.A.) Llc Oxazolone derivatives and uses thereof
IT1312310B1 (it) * 1999-05-07 2002-04-15 Recordati Ind Chimica E Farma Uso di antagonisti selettivi del recettore adrenergico a 1b per ilmiglioramento della disfunzione sessuale
ITMI20012060A1 (it) * 2001-10-05 2003-04-05 Recordati Chem Pharm Nuovi eterocilcli n-acilati
US7071197B2 (en) 2002-06-14 2006-07-04 Recordati S.A. N,N-disubstituted diazocycloalkanes
US20040058962A1 (en) * 2002-06-14 2004-03-25 Amedeo Leonardi Phenylalkylamines and pyridylalkylamines
US20040072839A1 (en) * 2002-06-14 2004-04-15 Amedeo Leonardi 1-Phenylalkylpiperazines
JP4769082B2 (ja) * 2003-12-17 2011-09-07 武田薬品工業株式会社 ウレア誘導体、その製造法及び用途
US20060264442A1 (en) * 2005-05-18 2006-11-23 Allergan, Inc. Methods for the treatment of ocular and neurodegenerative conditions in a mammal
US9452990B2 (en) 2012-06-20 2016-09-27 Novartis Ag Complement pathway modulators and uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE925468C (de) * 1941-08-13 1955-03-21 Hoechst Ag Verfahren zur Herstellung von ª†, ª†-Diaryl-propyl-aminen
GB679676A (en) * 1950-04-03 1952-09-24 Dow Chemical Co Improved method for the production of salts of aromatic-oxy-aliphatic carboxylic acids
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
US3663706A (en) * 1969-09-29 1972-05-16 Pfizer Use of 2,4-diaminoquinazolines as hypotensive agents
DE2143730A1 (de) * 1971-09-01 1973-03-08 Byk Gulden Lomberg Chem Fab Substituierte pyridine, verfahren zu deren herstellung und sie enthaltende arzneimittel
US4044136A (en) * 1972-09-09 1977-08-23 Pfizer Inc. Aminoquinazoline therapeutic agents
US4026894A (en) * 1975-10-14 1977-05-31 Abbott Laboratories Antihypertensive agents
US4062844A (en) * 1976-09-20 1977-12-13 Pfizer Inc. Process for preparing hypotensive 2-(4-aroylpiperazin-1-yl)-amino-6,7-dimethoxyquinazolines
FR2389614A1 (en) * 1977-05-05 1978-12-01 Synthelabo Antihypertensive 2,4-di:amino-quinazoline(s) - prepd. from a 2-halo-4-amino-quinazoline and a secondary amine
US4607034A (en) * 1979-10-29 1986-08-19 Mitsubishi Yuka Pharmaceutical Co., Ltd. Quinazoline derivatives and pharmaceutical composition thereof
GB2068961B (en) * 1980-02-13 1983-11-30 Sankyo Co Quinazoline derivatives
CS236097B1 (en) * 1983-06-01 1985-05-15 Jan Koenig Acylderivatives of 2-piperazinochinazoline and method of their preparation
AT384218B (de) * 1985-12-04 1987-10-12 Gerot Pharmazeutika Verfahren zur herstellung von neuen chinazolin-derivaten
US5110927A (en) * 1987-12-31 1992-05-05 The United States Of America As Represented By The Department Of Health And Human Services Prazosin analog with increased selectivity and duration of action

Also Published As

Publication number Publication date
IT1270993B (it) 1997-05-26
TW416951B (en) 2001-01-01
EP0750614A1 (en) 1997-01-02
DE69521037D1 (de) 2001-06-28
IL113024A0 (en) 1995-06-29
ZA952208B (en) 1995-12-28
IL113024A (en) 2000-07-26
JPH09511238A (ja) 1997-11-11
ITMI940506A1 (it) 1995-09-18
ES2158938T3 (es) 2001-09-16
AU1894895A (en) 1995-10-09
EP0750614B1 (en) 2001-05-23
JP3683911B2 (ja) 2005-08-17
ATE201400T1 (de) 2001-06-15
PT750614E (pt) 2001-10-31
US5798362A (en) 1998-08-25
DK0750614T3 (da) 2001-09-10
DE69521037T2 (de) 2001-10-25
GR3036443T3 (en) 2001-11-30
WO1995025726A1 (en) 1995-09-28

Similar Documents

Publication Publication Date Title
FI954829L (fi) Aroyylipiperidiinijohdannaiset
NO952854D0 (no) 1-arylpyrimidin-derivater
DE59508427D1 (de) 3-aryl-4-hydroxy-delta 3 -dihydrothiophenon-derivate
EP0708091A3 (en) Indoloyl-guanidines derivatives
DE69430587D1 (de) Pyrimidin-acyclonukleosid-derivate
ITMI940506A0 (it) Derivati chinzolilamminici attivi come alfa-antagonisti
FI971227A7 (fi) Pyramidinyylipyratsolijohdannaisia
IT1277073B1 (it) Derivati antraciclinici
ITMI941463A0 (it) Derivati eterociclo-condensatori di morfinoidi
IT1277597B1 (it) Derivati di diarilalchenilammina
IT1307327B1 (it) Derivati idroisochinolinici sostituiti
DE69527786D1 (de) Diaminomethyliden-derivate
FI964853L (fi) Deasetoksitaksolijohdannaiset
DE59509209D1 (de) Diphenyloxazolin-derivate
DE69510792D1 (de) Naphtochinonderivate
FI955026L (fi) Alkyyli-5-metyylisulfonyylibentsoyyliguanidiinijohdannaisia
ITMI941191A0 (it) 1-b-metil-2-tiol carbapen derivati
FI963122A7 (fi) Karbamoyylimetyyliureajohdannaiset
IT1273539B (it) Hals-fosfoniti come agenti stabilizzanti
IT1277115B1 (it) Hals-fosforammidi come agenti stabilizzanti
ITMI940467A0 (it) Derivati idantoinici
ITMI940202A0 (it) Derivati di idroisochinolina
ITMI940203A0 (it) Derivati di idroisochinolina
ITMI941863A0 (it) Derivati idrosochinolinici sostiuiti
ITMI941688A0 (it) Nuovi derivati isocefalosporanici

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970327